Director Declaration.


    23 April 2026 15:00:16
  • Source: Sharecast
RNS Number : 7133B
Reckitt Benckiser Group PLC
23 April 2026
 

23 April 2026

 

RECKITT BENCKISER GROUP PLC

 

Director Declaration

 

Reckitt Benckiser Group plc ('Reckitt') announces that Harry Kirsch, a Non-Executive Director for Reckitt, has been appointed as a Director on the Board of Galderma (SIX: GALD), from 22 April 2026.

 

This notification is made in accordance with Listing Rule 9.6.14 of the FCA's Listing Rules.

 

CONTACT DETAILS:

 

Contacts

 

Nick Ashworth                                                              +44 (0) 7408 812350

SVP Investor Relations

 

Catheryn O'Rourke                                                      +44 (0) 1753 217 800

General Counsel & Company Secretary

 

 

About Reckitt:  

We make the products people trust to care for the ones they love. We are home to some of the world's best-loved consumer health and hygiene brands, including Dettol, Durex, Finish, Gaviscon, Harpic, Lysol, Mucinex, Nurofen, Strepsils, Vanish and Veet. Consumers are at the heart of everything we do. By creating innovative, science-backed solutions, we support people every day to live healthier lives. 

 

Reckitt exists to protect, heal and nurture in the pursuit of a cleaner, healthier world. This commitment goes beyond the products we make. Through our actions, we expand access to healthcare, education and economic opportunities. We support the planet by reducing waste, conserving resources and driving sustainable innovation. 

 

We believe good health starts at home. With every action we take, we strive to make our consumers' lives easier, cleaner and healthier, to strengthen communities and to create a more sustainable future.

 

Find out more or get in touch with us at www.reckitt.com.

 

*Reckitt is the trading name of the Reckitt Benckiser group of companies

 

 

Reckitt Benckiser Group plc's LEI code is 5493003JFSMOJG48V108

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RDNIJMJTMTBTBIF

Compare our accounts

If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.

Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.